Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12241653

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2002 Aug 17
First author
International Collaborative Ovarian Neoplasm Group

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2003 Feb 22;361(9358):706
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2002 Aug 17;360(9332):500-1. doi: 10.1016/s0140-6736(02)09757-x.
    note
    Source null
    related pmid
    12241648
    relationship
    Comment in
  3. citation
    Lancet. 2002 Dec 21-28;360(9350):2086-7; author reply 2088. doi: 10.1016/S0140-6736(02)11984-2.
    note
    Source null
    related pmid
    12504453
    relationship
    Comment in
  4. citation
    Lancet. 2002 Dec 21-28;360(9350):2087-8; author reply 2088. doi: 10.1016/s0140-6736(02)11986-6.
    note
    Source null
    related pmid
    12504454
    relationship
    Comment in
  5. citation
    Lancet. 2002 Dec 21-28;360(9350):2087; author reply 2088. doi: 10.1016/s0140-6736(02)11985-4.
    note
    Source null
    related pmid
    12504455
    relationship
    Comment in

Authors and identifiers

  1. name
    International Collaborative Ovarian Neoplasm Group
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    International Collaborative Ovarian Neoplasm Group
    type
    CollectiveName
bibliography ids
  1. nci-bib-e8afa703dbc4d577252af5dc
book metadata
content sha256
e996eb09dbc54cee95fc0e11a52f4cc9d079802bf18202fb68ef267467c6dea1
document type
citation
dois
  1. 10.1016/S0140-6736(02)09738-6
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12241653
immutable id
pubmed:12241653@e996eb09dbc54cee95fc0e11a52f4cc9d079802bf18202fb68ef267467c6dea1
journal
abbreviation
Lancet
issn electronic
Source null
issn print
0140-6736
issue
9332
name
Lancet (London, England)
nlm unique id
2985213R
pages
505-15
volume
360
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2003 Feb 22;361(9358):706
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet. 2002 Aug 17;360(9332):500-1. doi: 10.1016/s0140-6736(02)09757-x.
    note
    Source null
    related pmid
    12241648
    relationship
    Comment in
  3. citation
    Lancet. 2002 Dec 21-28;360(9350):2086-7; author reply 2088. doi: 10.1016/S0140-6736(02)11984-2.
    note
    Source null
    related pmid
    12504453
    relationship
    Comment in
  4. citation
    Lancet. 2002 Dec 21-28;360(9350):2087-8; author reply 2088. doi: 10.1016/s0140-6736(02)11986-6.
    note
    Source null
    related pmid
    12504454
    relationship
    Comment in
  5. citation
    Lancet. 2002 Dec 21-28;360(9350):2087; author reply 2088. doi: 10.1016/s0140-6736(02)11985-4.
    note
    Source null
    related pmid
    12504455
    relationship
    Comment in
outcomes validated
false
pmid
12241653
provenance
batch id
ced7794d3512d3f45188
provider
NCBI PubMed ESummary
record sha256
dcaffbc65489dd2c3567b129201d9ce1f647d05dbe132b47ed978ef46c677e12
response sha256
782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
retrieved at
2026-09-09T23:45:46.208577+00:00
publication date
display
2002 Aug 17
precision
day
year
2002
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12241653/
title
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial.

Preserved source evidence · Not medical advice